C07J 71/0036
Nitrogen-containing hetero ring
Official title: {Nitrogen-containing hetero ring}
C07J71/0036 (Nitrogen-containing hetero ring) appears on 145 US grants and 78 published applications in this corpus.
Search patents in C07J- Granted patents
- 145
- Published applications
- 78
- Assignees
- 82
- Inventors
- 361
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 5 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 4 | 0 |
| 1981 | 2 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 5 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 0 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 3 | 0 |
| 1994 | 0 | 0 |
| 1995 | 5 | 0 |
| 1996 | 7 | 0 |
| 1997 | 2 | 0 |
| 1998 | 7 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 1 |
| 2002 | 3 | 4 |
| 2003 | 3 | 2 |
| 2004 | 0 | 9 |
| 2005 | 1 | 3 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 2 | 4 |
| 2011 | 1 | 8 |
| 2012 | 3 | 4 |
| 2013 | 4 | 3 |
| 2014 | 5 | 2 |
| 2015 | 1 | 2 |
| 2016 | 1 | 3 |
| 2017 | 4 | 6 |
| 2018 | 4 | 2 |
| 2019 | 3 | 3 |
| 2020 | 1 | 3 |
| 2021 | 3 | 4 |
| 2022 | 0 | 3 |
| 2023 | 3 | 3 |
| 2024 | 1 | 1 |
| 2025 | 2 | 3 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease10 Mar 2026US 12,570,687 B2NucMito Pharmaceuticals Co. Ltd.
- C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof1 Jul 2025US 12,344,631 B2Reata Pharmaceuticals, Inc.
- Betulastatin compounds25 Mar 2025US 12,258,370 B2Arizona Board of Regents on behalf of Arizona State University
- Anti-cancer nuclear hormone receptor-targeting compounds9 Apr 2024US 11,952,349 B2Nuvation Bio Inc.
- Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport18 Jul 2023US 11,701,369 B2Huahui Health Ltd.
- C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof27 Nov 2025US 2025/0361263 A1Reata Pharmaceuticals, Inc.
- Chaga mushroom-related formulations, chemical compounds, and methods of production and use thereof28 Aug 2025US 2025/0268965 A1Gerosynth Laboratories, Inc.
- Betulastatin compounds14 Aug 2025US 2025/0257093 A1Arizona Board of Regents on behalf of Arizona State University
- Compositions and methods for treating cns disorders28 Mar 2024US 2024/0101592 A1Sage Therapeutics, Inc.
- Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammation29 Jun 2023US 2023/0203089 A1Taro Pharmaceuticals Inc.
Most cited
By later US patents
- vitamin D.sub.3 derivatives having a substituent at 2-position96US 4,666,634 AChugai Seiyaku Kabushiki Kaisha · 1987
- 11 .beta.-substituted progesterone analogs47US 4,954,490 AResearch Triangle Institute · 1990
- 11 .beta.-substituted progesterone analogs39US 5,073,548 AResearch Triangle Institute · 1991
- Corticoid-17-(alkyl carbonates) and process for their manufacture32US 4,377,575 AHoechst Aktiengesellschaft · 1983
- Method for treating metabolic bone disease in mammals29US 4,588,716 AWisconsin Alumni Research Foundation · 1986